日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Broad-spectrum antitumor analysis of the telomerase activity inhibitor TPCH derived from the human constitutively expressed protein LPTS/PinX1.

对源自人类组成型表达蛋白 LPTS/PinX1 的端粒酶活性抑制剂 TPCH 进行广谱抗肿瘤分析

Zhou Hongchang, Zhang Xiaoying, Wang Yao, Wu Yongqiang, Wang Ling, Hu Chen, Zhang Ting, Zhang Hui, You Dian, Zhao Mengli, Zhao Mujun, Li Anqi, Chen Guangming

PinX1 plays multifaceted roles in human cancers: a review and perspectives

PinX1在人类癌症中发挥多重作用:综述与展望

You, Dian; Tong, Kaiwen; Li, Yuan; Zhang, Ting; Wu, Yongqiang; Wang, Ling; Chen, Guangming; Zhang, Xiaoying

A light-driven dual-nanotransformer with deep tumor penetration for efficient chemo-immunotherapy

具有深度肿瘤穿透能力的光驱动双纳米变压器可用于有效的化学免疫治疗

Jiahui Peng, Fangman Chen, Yulu Liu, Fan Zhang, Lei Cao, Qiannan You, Dian Yang, Zhimin Chang, Mingfeng Ge, Li Li, Zheng Wang, Qian Mei, Dan Shao, Meiwan Chen, Wen-Fei Dong

Meropenem for children with severe pneumonia: Protocol for a randomized controlled trial

美罗培南治疗儿童重症肺炎:一项随机对照试验方案

Tian, Xue; Dong, Lei; Jiang, Ting-Ting; Tang, Bo-Hao; Wang, Ze-Ming; Wu, Yue-E; You, Dian-Ping; Bi, Jing; Qian, Su-Yun; Qi, Hui; Shen, A-Dong

Developmental Population Pharmacokinetics-Pharmacodynamics of Meropenem in Chinese Neonates and Young Infants: Dosing Recommendations for Late-Onset Sepsis

美罗培南在中国新生儿和婴幼儿中的发育人群药代动力学-药效学:晚发型败血症的给药建议

Wu, Yue-E; Kou, Chen; Li, Xue; Tang, Bo-Hao; Yao, Bu-Fan; Hao, Guo-Xiang; Zheng, Yi; van den Anker, John; You, Dian-Ping; Shen, A-Dong; Zhao, Wei

Optimal Dosing of Ceftriaxone in Infants Based on a Developmental Population Pharmacokinetic-Pharmacodynamic Analysis

基于发育人群药代动力学-药效学分析的头孢曲松在婴儿中的最佳剂量

Wang, Ya-Kun; Wu, Yue-E; Li, Xue; Tian, Li-Yuan; Khan, Muhammad Wasim; Tang, Bo-Hao; Shi, Hai-Yan; Zheng, Yi; Hao, Guo-Xiang; van den Anker, John; You, Dian-Ping; Zhao, Wei